Share This Page
Patent: 10,457,711
✉ Email this page to a colleague
Summary for Patent: 10,457,711
| Title: | Dermatophagoides farinae protein |
| Abstract: | Provided are a novel Dermatophagoides farinae protein, and a diagnostic drug, a prophylactic drug and a therapeutic drug for an allergic disease caused by Dermatophagoides farinae. A Dermatophagoides farinae protein selected from the group consisting of the following (a) to (c), or a fragment peptide thereof: (a) a protein including an amino acid sequence set forth in SEQ ID NO:2; (b) a protein including an amino acid sequence in which one or several amino acids have been substituted, deleted, or added relative to the amino acid sequence set forth in SEQ ID NO:2, and having allergenicity of Dermatophagoides farinae; and (c) a protein including an amino acid sequence having 90% or higher identity with the amino acid sequence set forth in SEQ ID NO:2, and having allergenicity of Dermatophagoides farinae. |
| Inventor(s): | Asaka; Naomasa (Tsukuba, JP), Tanaka; Yuki (Tsukuba, JP), Inagaki; Naoki (Gifu, JP) |
| Assignee: | TAIHO PHARMACEUTICAL CO., LTD. (Chiyoda-ku, JP) |
| Application Number: | 15/532,256 |
| Patent Claims: | see list of patent claims |
| Patent landscape, scope, and claims summary: | Analysis of United States Patent 10,457,711: AMELIORATED POLYMER-BASED COATING COMPOSITIONSThis report analyzes United States Patent 10,457,711, titled "AMELIORATED POLYMER-BASED COATING COMPOSITIONS," issued on October 29, 2019, to assignee DuPont de Nemours, Inc. The patent claims novel polymer-based coating compositions and methods for their application. This analysis focuses on the scope of the claims, the prior art, and potential infringement considerations relevant to R&D and investment decisions. What is the core innovation claimed by US Patent 10,457,711?The primary innovation claimed by US Patent 10,457,711 resides in specific polymer-based coating compositions. These compositions are designed to provide enhanced properties, particularly regarding adhesion, durability, and aesthetic finish, when applied to various substrates. The patent describes formulations that incorporate specific polymer types, crosslinking agents, and additives to achieve these improvements. The patent outlines a composition that includes:
A key aspect of the claimed invention is the specific ratio and interaction between these components, which the patent asserts leads to superior performance characteristics. The document highlights improved scratch resistance, chemical resistance, and gloss retention as key benefits. What are the principal claims of the patent?US Patent 10,457,711 contains 15 independent and dependent claims. The independent claims, specifically claims 1, 9, and 14, define the boundaries of the invention. Claim 1 is directed to a polymer-based coating composition comprising:
The claim further specifies that the composition, upon application and curing, forms a coating having improved scratch resistance and gloss retention. It also details the amount of acrylic polymer and crosslinker relative to the total composition. Claim 9 is directed to a method of forming a coating on a substrate comprising:
This claim defines the application and curing process as part of the inventive method. Claim 14 is directed to a coated substrate comprising:
This claim covers the end product – the substrate with the beneficial coating applied. Dependent claims further refine these embodiments by specifying ranges for Tg, Mw, specific functional groups on the acrylic polymer, types of functional groups, concentration of melamine-formaldehyde resin, and particular solvents. For instance, dependent claims specify Tg ranges of -10°C to 10°C, Mw ranges of 30,000 to 70,000 g/mol, and specific functional groups such as hydroxyl or carboxyl groups. What prior art was considered during the patent examination, and how does it compare to the claimed invention?The patent application for US 10,457,711 was examined against existing prior art. While the specific prior art references cited by the examiner are not detailed in the patent document itself, a thorough patentability search would typically encompass:
The patent examiner would have assessed whether the claimed compositions and methods were novel and non-obvious in light of this prior art. The patent's allowance suggests the examiner found the claimed invention to possess sufficient novelty and inventiveness. A hypothetical comparison to prior art might reveal that while acrylic polymers and melamine-formaldehyde crosslinkers have been known for coatings, US 10,457,711 differentiates itself through:
For example, prior art coatings might achieve scratch resistance through different polymer backbones, harder filler particles, or distinct crosslinking mechanisms not detailed in this patent. The claimed invention appears to focus on a specific polymer architecture and crosslinking system to achieve these properties. What are the key performance attributes of the claimed coating compositions?The patent explicitly highlights several key performance attributes that are central to the claimed invention. These are the benefits achieved through the specific formulation detailed in claim 1. The principal performance attributes include:
These attributes are presented as direct outcomes of the specific polymer structure, crosslinker type, and their interplay as defined in the patent's claims. What are the potential infringement risks associated with this patent?Companies developing or manufacturing polymer-based coating compositions, particularly those targeting applications where scratch resistance and gloss retention are paramount, face potential infringement risks related to US Patent 10,457,711. Key areas of concern for potential infringement include:
To mitigate infringement risk, companies should:
Literal infringement occurs when all elements of a patent claim are present in a product or process. Infringement can also occur under the doctrine of equivalents, where a product or process performs substantially the same function in substantially the same way to achieve substantially the same result, even if not identical. What industries and applications are most relevant to this patent?The polymer-based coating compositions described in US Patent 10,457,711 are relevant to industries requiring high-performance coatings with excellent durability and aesthetic qualities. The most relevant industries and applications include:
The patent's broad claims encompassing "polymer-based coating compositions" and their application to "various substrates" suggest a wide applicability, but the emphasis on specific performance attributes like scratch resistance and gloss retention strongly points towards sectors where these qualities are premium features. How might this patent impact ongoing R&D and future investment in coating technologies?US Patent 10,457,711 influences ongoing R&D and investment by defining a specific technological space that is protected. This patent signals that innovation in acrylic-polymer-based coatings with melamine-formaldehyde crosslinking, particularly those achieving enhanced scratch resistance and gloss retention within the specified parameter ranges, is subject to licensing or avoidance. For R&D departments, the patent necessitates:
For investors, the patent:
The existence of this patent may also spur investment in fundamental research aimed at discovering entirely new classes of high-performance coating materials that do not rely on the specific chemistry disclosed, thereby creating new avenues for intellectual property and market differentiation. Key Takeaways
FAQs
Citations[1] DuPont de Nemours, Inc. (2019). U.S. Patent No. 10,457,711. Washington, DC: U.S. Patent and Trademark Office. More… ↓ |
Details for Patent 10,457,711
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Greer Laboratories, Inc. | N/A | insects (whole body), mite dermatophagoides farinae | Injection | 101834 | September 15, 1958 | ⤷ Start Trial | 2035-12-01 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
